Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06333275

Restoration of Immunity to Vaccine Preventable Diseases After CART-T Cell Therapy

Sponsor: Insel Gruppe AG, University Hospital Bern

View on ClinicalTrials.gov

Summary

The goal of this observational study is to learn about vaccine immunity in patients with B-cell malignancies treated by chimeric antigen receptor T-cell therapies (CAR-T). The main questions it aims to answer are: * Do CAR-T cell therapy recipients lose vaccine protection against common vaccine-preventable pathogens * Are current re-vaccination recommendations sufficient in restoring vaccine-protection * Is this restored vaccine-protection after CAR-T cell therapy lost faster than usual * Do clinical or immunological factors predict vaccine response after CAR-T cell therapy

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

80

Start Date

2023-11-14

Completion Date

2026-12

Last Updated

2024-03-27

Healthy Volunteers

No

Interventions

BIOLOGICAL

Vaccines against: Diphtheria, tetanus, pertussis, polio, haemophilus influenza type b, varicella and measles

First immunization course (6±1 months post CAR-T treatment): 1. Diphtheria, tetanus, pertussis, polio, haemophilus influenza type b (as by the Swiss guidelines\[FOPH\] all of these are administered in one combined vaccine; INFANRIX DTPa-IPV+Hib Inj Susp®; GlaxoSmithKline) 2. Hepatitis B (Engerix B®, GlaxoSmithKline) 3. 13-valent Streptococcus pneumonia vaccine (Prevenar-13®; Pfizer) 4. Herpes zoster vaccine in patients with documented prior seropositivity or known varicella-infection in patient history (as by The Swiss guidelines; Shingrix®; GlaxoSmithKline) 5. Tick-borne encephalitis (as by The Swiss guidelines; FSME Immun CC®; Pfizer or Encepur N®, BavarianNordic; these vaccines can be used interchangeably) Second immunization course (12±1 months post CAR-T treatment): 1. Mumps, measles, rubella (Priorix®, GlaxoSmithKline) 2. Varicella zoster vaccine (as by guidelines; Varilrix®, GlaxoSmithKline) If seronegative/patient history negative

Locations (1)

University Hospital Bern

Bern, Switzerland